e-branch
Login
My List - 0
Help
Home
My Account/Renew Loans
Community Info
KidSearch
New Catalogue!
Search
Advanced
By Format
By Number
My Searches
Can't Find it?
Find Magazine Articles & more
Problems?
Search:
Title Starts with...
Title Keyword(s)
Author/Performer/Name (Last,First)
Author/Performer/Name Keyword(s)
Subject Starts with...
Subject Keyword(s)
Series Starts with...
Series Keyword(s)
Anyword/Anywhere
List Name Keyword(s)
Refine Search
> You're searching:
Halifax Public Libraries
Item Information
Copy / Holding Information
Booklist Review
Library Journal Review
Publisher Weekly Review
Table of Contents
More Content
More by this author
Hughes, Evan, 1975-
Subjects
Insys Therapeutics, Inc.
Opioids -- Marketing.
Pharmaceutical industry -- Corrupt practices.
Browse Catalog
by author:
Hughes, Evan, 1975-
by title:
The hard sell : crim...
by call number:
338.476153 H893h
Search the Web
Hughes, Evan, 1975-
Insys Therapeutics, Inc.
Opioids -- Marketing.
Pharmaceutical industry -- Corrupt practices.
MARC Display
The hard sell : crime and punishment at an opioid startup / Evan Hughes.
by
Hughes, Evan, 1975-
Doubleday, 2022.
Call #:
338.476153 H893h
Subjects
Insys Therapeutics, Inc.
Opioids
--
Marketing
.
Pharmaceutical industry
--
Corrupt practices.
ISBN:
9780385544900 (hc)
9780525566328 (trade pbk)
Edition:
1st ed.
Description:
x, 273 p. ; 25 cm.
Bibliography:
Includes bibliographical references (p. [237]-273).
Summary:
"The blistering inside story of a startup that made millions pushing
opioids
--
until its cutthroat tactics were exposed and its executives put behind bars John Kapoor had amassed a small fortune in pharmaceuticals when he conceived of a new product. It was the 2000s, and
opioids
were big business. If Kapoor, an immigrant and the billionaire founder of Insys, could find a new way to administer the highly potent fentanyl, he could patent his invention and sell it to those in need-at a steep price. The only problem: There weren't enough people in need. Kapoor's drug was approved for breakthrough cancer pain. If Subsys was going to turn a profit, the company would need to persuade doctors to prescribe it 'off-label,' for other, lesser forms of pain. This is the story of how Insys turned a niche drug into big business. With executives leading the charge, Insys sales reps seduced doctors with charm, money, and sex. Its administrators lied to health care providers, claiming recipients had cancer when they did not. It pushed drugs onto patients that would have benefited from safer options, or no drugs at all. The strategy worked: When Insys went public, it notched the biggest IPO of its year. But several employees reached their limit and quietly blew the whistle, bringing the full force of the justice system upon the drug maker. In The Hard Sell, author and National Magazine Award-finalist Evan Hughes lays bare the pharma playbook. He shows how drug makers like Insys, fueled by greed and a hunger for market share, turn deception into profit. The book represents a stunning vindication, but also a cautionary tale. As Hughes shows, Insys didn't do anything its competitors weren't also doing. It was simply worse at covering its tracks."--Publisher.
Holds:
0
Copy/Holding information
Location
Collection
Call No.
Item type
Status
Due Date
Central Library
Adult Nonfiction
338.476153 H893h
Adult books
Checked out
Jul 16, 2024
Add Copy to MyList
Sackville Public Library
Adult Nonfiction
338.476153 H893h
Adult books
Checked in
Add Copy to MyList
Horizon Information Portal 3.24_8902M
© 2001-2013
SirsiDynix
All rights reserved.